[시장보고서]조제 약국 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

조제 약국 시장 : 세계 산업 분석, 규모, 점유율, 성장, 동향, 예측(2024-2034년)

Compounding Pharmacy Market; - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034

상품코드 : 1706756

리서치사 : Transparency Market Research

발행일 : 2025년 02월

페이지 정보 : 영문 257 Pages

라이선스 & 가격 (부가세 별도)

US $ 5,795

￦ 8,316,000

PDF (Single User License)

PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 8,795

￦ 12,622,000

PDF (Multi-user License)

PDF 보고서를 동일 부서 5명이 이용할 수 있는 라이선스입니다. 텍스트 등의 Copy & Paste가 가능합니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

US $ 11,795

￦ 16,928,000

PDF (Corporate License)

PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.

한글목차

샘플 요청 목록에 추가

조제 약국 시장 - 조사 범위

TMR의 조사 리포트 '세계의 조제 약국 시장'은 2024-2034년의 예측 기간에 시장의 지표에 대한 귀중한 인사이트를 얻기 위해 과거뿐만 아니라 현재의 성장 동향과 기회도 조사했습니다. 이 보고서는 2024년을 기준 연도, 2034년을 예측연도로 하여 2018-2034년 세계 조제 약국 시장의 매출과 예측을 제공합니다. 또한 2024-2034년 세계 조제 약국 시장의 연평균 성장률(CAGR%)을 제시합니다.

이 보고서는 광범위한 1차 조사, KOL(Key Opinion Leader), 업계 리더, 오피니언 제조업체를 대상으로 한 인터뷰, 주요 기업의 제품 자료, 연례 보고서, 보도자료, 관련 자료 등을 참조하여 조제 약국 시장을 추론하는 2차 조사를 통해 작성되었습니다. 시장을 추론했습니다.

시장 스냅숏
2023년 시장 규모	134억 7,460만 달러
2034년 시장 규모	268억 3,880만 달러
CAGR	6.5%

세계의 조제 약국 시장의 경쟁 구도에 대해 조사하고 있습니다. 세계의 조제 약국 시장에서 사업을 운영하는 주요 기업이 식별되고, 각 기업이 다양한 속성에서 프로파일링되고 있습니다. 기업 개요, 재무 상황, 최근 동향, SWOT가 이 리포트에서 소개되고 있는 세계의 조제 약국 시장에서 플레이어의 속성입니다.

의약품 조제를 지원하는 기술의 진보
사내 및 외부 위탁 의약품 조제에 관한 인사이트
의약품 조제의 이점과 잠재적 리스크에 관한 논의
주요 지역/국가에서 조제 약국 리스트
주요 지역/국가에서 규제 시나리오
Porter's Five Forces 분석
PESTEL 분석
밸류체인 분석
신규 시장 진출 업체를 위한 시장 개발 전략
주요 업계 이벤트

제6장 세계의 시장 분석과 예측 : 약국 유형별

서론과 정의
주요 조사 결과/진전
시장 금액 예측 약국 유형별, 2020-2034년
- 503A 약국
- 503B 약국
약국 유형별 시장의 매력

제7장 세계의 시장 분석과 예측 : 배합 유형별

서론과 정의
주요 조사 결과/진전
시장 금액 예측 배합 유형별, 2020-2034년
- 의약품 성분 변경(PIA)
- 의약품 부족 제조
- 의약품 투여량 변경(PDA)
배합 유형별 시장의 매력

제8장 세계의 시장 분석과 예측 : 불임증별

서론과 정의
주요 조사 결과/진전
시장 금액 예측 불임증에 의해 2020-2034년
- 멸균
- 비멸균
불임증에 의한 시장의 매력

제9장 세계의 시장 분석과 예측 : 제형별

서론과 정의
주요 조사 결과/진전
시장 금액 예측제형별, 2020-2034년
- 경구약
  - 캡슐
  - 태블릿
  - 서스펜션
  - 기타(츄어블정 등)
- 외용약
  - 크림
  - 겔
  - 연고
  - 기타(페이스트 등)
- 주사제
- 좌약
- 기타
제형별 시장의 매력

제10장 세계의 시장 분석과 예측 : 용도별

서론과 정의
주요 조사 결과/진전
시장 금액 예측 : 용도별, 2020-2034년
- 호르몬 대체요법
- 통증 관리
- 신경학
- 피부과
- 안과
- 식이보충제
- 기타(이비인후과, 갑상선 질환 등)
용도별 시장의 매력

제11장 세계의 시장 분석과 예측 : 환자층별

서론과 정의
주요 조사 결과/진전
시장 금액 예측 환자 인구통계별, 2020-2034년
- 인간
  - 소아과
  - 성인용
  - 고령자
- 수의
환자층별 시장의 매력

제12장 세계의 시장 분석과 예측 : 지역별

주요 조사 결과
시장 금액 예측 : 지역별
- 북미
- 유럽
- 아시아태평양
- 라틴아메리카
- 중동 및 아프리카
국가·지역별 시장의 매력

제13장 북미의 시장 분석과 예측

미국
캐나다

제14장 유럽의 시장 분석과 예측

독일
영국
프랑스
이탈리아
스페인
기타 유럽 지역

제15장 아시아태평양의 시장 분석과 예측

중국
인도
일본
호주와 뉴질랜드
기타 아시아태평양

제16장 라틴아메리카의 시장 분석과 예측

브라질
멕시코
기타 라틴아메리카 지역

제17장 중동 및 아프리카의 시장 분석과 예측

GCC 국가
남아프리카공화국
기타 중동 및 아프리카

제18장 경쟁 구도

시장 기업 - 경쟁 매트릭스(기업 계층별·규모별)
시장 점유율 분석 기업별(2023년)
기업 개요
- B. Braun SE
- WEDGEWOOD PHARMACY
- Fagron
- Fresenius Kabi AG
- Avella Specialty Pharmacy
- Aurora Health Care
- Walgreen Co.
- Formul8
- Triangle Compounding
- Apollo Clinical Pharmacy
- The London Specialist Pharmacy Ltd
- Olympia Pharmacy
- Fusion Apothecary
- Albertsons Companies, Inc.
- JL Diekman and AQ Touchard
- Roseway Labs
- Hill's and Milford Pharmacy
- Other Prominent Players

KSA

영문 목차

영문목차

Compounding Pharmacy Market - Scope of Report

TMR's report on the global compounding pharmacy market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global compounding pharmacy market for the period 2018-2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global compounding pharmacy market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players' product literature, annual reports, press releases, and relevant documents to understand the compounding pharmacy market.

Market Snapshot
Market Value in 2023	US$ 13474.6 Mn
Market Value in 2034	US$ 26838.8 Mn
CAGR	6.5%

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global compounding pharmacy market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global compounding pharmacy market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global compounding pharmacy market.

The report delves into the competitive landscape of the global compounding pharmacy market. Key players operating in the global compounding pharmacy market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global compounding pharmacy market profiled in this report.

Key Questions Answered in Global compounding pharmacy Market Report:

What is the sales/revenue generated by compounding pharmacy across all regions during the forecast period?
What are the opportunities in the global compounding pharmacy market?
What are the major drivers, restraints, opportunities, and threats in the market?
Which regional market is set to expand at the fastest CAGR during the forecast period?
Which segment is expected to generate the highest revenue globally in 2034?
Which segment is projected to expand at the highest CAGR during the forecast period?
What are the market positions of different companies operating in the global market?

Compounding Pharmacy Market - Research Objectives and Research Approach

The comprehensive report on the global compounding pharmacy market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global compounding pharmacy market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global compounding pharmacy market.

1. Preface

1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Compounding Pharmacy Market

4. Market Overview

4.1. Introduction
- 4.1.1. Segment Definition
- 4.1.2. Industry Evolution / Developments
4.2. Overview
4.3. Market Dynamics
- 4.3.1. Drivers
- 4.3.2. Restraints
- 4.3.3. Opportunities
4.4. Global Compounding Pharmacy Market Analysis and Forecasts, 2020-2034
- 4.4.1. Market Revenue Projections (US$ Mn)

5. Key Insights

5.1. Technological Advancements that assist Pharmaceutical Compounding
5.2. Insights on In-house and Outsourced Pharmaceutical Compounding
5.3. Discussion on Benefits and Potential Risks of Pharmaceutical Compounding
5.4. List of Compounding Pharmacies across Key Region / Countries
5.5. Regulatory Scenario across Key Regions / Countries
5.6. PORTER's Five Forces Analysis
5.7. PESTEL Analysis
5.8. Value Chain Analysis
5.9. Go-to-Market Strategy for New Market Entrants
5.10. Key Industry Events

6. Global Compounding Pharmacy Market Analysis and Forecasts, By Pharmacy Type

6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast By Pharmacy Type, 2020-2034
- 6.3.1. 503A Pharmacies
- 6.3.2. 503B Pharmacies
6.4. Market Attractiveness By Pharmacy Type

7. Global Compounding Pharmacy Market Analysis and Forecasts, By Compounding Type

7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast By Compounding Type, 2020-2034
- 7.3.1. Pharmaceutical Ingredient Alteration (PIA)
- 7.3.2. Drug Shortage Manufacturing
- 7.3.3. Pharmaceutical Dosage Alteration (PDA)
7.4. Market Attractiveness By Compounding Type

8. Global Compounding Pharmacy Market Analysis and Forecasts, By Sterility

8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast By Sterility, 2020-2034
- 8.3.1. Sterile
- 8.3.2. Non-sterile
8.4. Market Attractiveness By Sterility

9. Global Compounding Pharmacy Market Analysis and Forecasts, By Dosage Form

9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast By Dosage Form, 2020-2034
- 9.3.1. Oral Medications
  - 9.3.1.1. Capsules
  - 9.3.1.2. Tablets
  - 9.3.1.3. Suspensions
  - 9.3.1.4. Others (Chewables, etc.)
- 9.3.2. Topical Medications
  - 9.3.2.1. Creams
  - 9.3.2.2. Gels
  - 9.3.2.3. Ointments
  - 9.3.2.4. Others (Paste, etc.)
- 9.3.3. Injectables
- 9.3.4. Suppositories
- 9.3.5. Others
9.4. Market Attractiveness By Dosage Form

10. Global Compounding Pharmacy Market Analysis and Forecasts, By Application

10.1. Introduction & Definition
10.2. Key Findings / Developments
10.3. Market Value Forecast By Application, 2020-2034
- 10.3.1. Hormone Replacement Therapy
- 10.3.2. Pain Management
- 10.3.3. Neurology
- 10.3.4. Dermatology
- 10.3.5. Ophthalmology
- 10.3.6. Nutritional Supplements
- 10.3.7. Others (ENT, Thyroid Disorders, etc.)
10.4. Market Attractiveness By Application

11. Global Compounding Pharmacy Market Analysis and Forecasts, By Patient Demographics

11.1. Introduction & Definition
11.2. Key Findings / Developments
11.3. Market Value Forecast By Patient Demographics, 2020-2034
- 11.3.1. Human
  - 11.3.1.1. Pediatric
  - 11.3.1.2. Adult
  - 11.3.1.3. Geriatric
- 11.3.2. Veterinary
11.4. Market Attractiveness By Patient Demographics

12. Global Compounding Pharmacy Market Analysis and Forecasts, By Region

12.1. Key Findings
12.2. Market Value Forecast By Region
- 12.2.1. North America
- 12.2.2. Europe
- 12.2.3. Asia Pacific
- 12.2.4. Latin America
- 12.2.5. Middle East & Africa
12.3. Market Attractiveness By Country/Region

13. North America Compounding Pharmacy Market Analysis and Forecast

13.1. Introduction
- 13.1.1. Key Findings
13.2. Market Value Forecast By Pharmacy Type, 2020-2034
- 13.2.1. 503A Pharmacies
- 13.2.2. 503B Pharmacies
13.3. Market Value Forecast By Compounding Type, 2020-2034
- 13.3.1. Pharmaceutical Ingredient Alteration (PIA)
- 13.3.2. Drug Shortage Manufacturing
- 13.3.3. Pharmaceutical Dosage Alteration (PDA)
13.4. Market Value Forecast By Sterility, 2020-2034
- 13.4.1. Sterile
- 13.4.2. Non-sterile
13.5. Market Value Forecast By Dosage Form, 2020-2034
- 13.5.1. Oral Medications
  - 13.5.1.1. Capsules
  - 13.5.1.2. Tablets
  - 13.5.1.3. Suspensions
  - 13.5.1.4. Others (Chewables, etc.)
- 13.5.2. Topical Medications
  - 13.5.2.1. Creams
  - 13.5.2.2. Gels
  - 13.5.2.3. Ointments
  - 13.5.2.4. Others (Paste, etc.)
- 13.5.3. Injectables
- 13.5.4. Suppositories
- 13.5.5. Others
13.6. Market Value Forecast By Application, 2020-2034
- 13.6.1. Hormone Replacement Therapy
- 13.6.2. Pain Management
- 13.6.3. Neurology
- 13.6.4. Dermatology
- 13.6.5. Ophthalmology
- 13.6.6. Nutritional Supplements
- 13.6.7. Others (ENT, Thyroid Disorders, etc.)
13.7. Market Value Forecast By Patient Demographics, 2020-2034
- 13.7.1. Human
  - 13.7.1.1. Pediatric
  - 13.7.1.2. Adult
  - 13.7.1.3. Geriatric
- 13.7.2. Veterinary
13.8. Market Value Forecast By Country, 2020-2034
- 13.8.1. U.S.
- 13.8.2. Canada
13.9. Market Attractiveness Analysis
- 13.9.1. By Pharmacy Type
- 13.9.2. By Compounding Type
- 13.9.3. By Sterility
- 13.9.4. By Dosage Form
- 13.9.5. By Application
- 13.9.6. By Patient Demographics
- 13.9.7. By Country

14. Europe Compounding Pharmacy Market Analysis and Forecast

14.1. Introduction
- 14.1.1. Key Findings
14.2. Market Value Forecast By Pharmacy Type, 2020-2034
- 14.2.1. 503A Pharmacies
- 14.2.2. 503B Pharmacies
14.3. Market Value Forecast By Compounding Type, 2020-2034
- 14.3.1. Pharmaceutical Ingredient Alteration (PIA)
- 14.3.2. Drug Shortage Manufacturing
- 14.3.3. Pharmaceutical Dosage Alteration (PDA)
14.4. Market Value Forecast By Sterility, 2020-2034
- 14.4.1. Sterile
- 14.4.2. Non-sterile
14.5. Market Value Forecast By Dosage Form, 2020-2034
- 14.5.1. Oral Medications
  - 14.5.1.1. Capsules
  - 14.5.1.2. Tablets
  - 14.5.1.3. Suspensions
  - 14.5.1.4. Others (Chewables, etc.)
- 14.5.2. Topical Medications
  - 14.5.2.1. Creams
  - 14.5.2.2. Gels
  - 14.5.2.3. Ointments
  - 14.5.2.4. Others (Paste, etc.)
- 14.5.3. Injectables
- 14.5.4. Suppositories
- 14.5.5. Others
14.6. Market Value Forecast By Application, 2020-2034
- 14.6.1. Hormone Replacement Therapy
- 14.6.2. Pain Management
- 14.6.3. Neurology
- 14.6.4. Dermatology
- 14.6.5. Ophthalmology
- 14.6.6. Nutritional Supplements
- 14.6.7. Others (ENT, Thyroid Disorders, etc.)
14.7. Market Value Forecast By Patient Demographics, 2020-2034
- 14.7.1. Human
  - 14.7.1.1. Pediatric
  - 14.7.1.2. Adult
  - 14.7.1.3. Geriatric
- 14.7.2. Veterinary
14.8. Market Value Forecast By Country/Sub-region, 2020-2034
- 14.8.1. Germany
- 14.8.2. U.K.
- 14.8.3. France
- 14.8.4. Italy
- 14.8.5. Spain
- 14.8.6. Rest of Europe
14.9. Market Attractiveness Analysis
- 14.9.1. By Pharmacy Type
- 14.9.2. By Compounding Type
- 14.9.3. By Sterility
- 14.9.4. By Dosage Form
- 14.9.5. By Application
- 14.9.6. By Patient Demographics
- 14.9.7. By Country/Sub-region

15. Asia Pacific Compounding Pharmacy Market Analysis and Forecast

15.1. Introduction
- 15.1.1. Key Findings
15.2. Market Value Forecast By Pharmacy Type, 2020-2034
- 15.2.1. 503A Pharmacies
- 15.2.2. 503B Pharmacies
15.3. Market Value Forecast By Compounding Type, 2020-2034
- 15.3.1. Pharmaceutical Ingredient Alteration (PIA)
- 15.3.2. Drug Shortage Manufacturing
- 15.3.3. Pharmaceutical Dosage Alteration (PDA)
15.4. Market Value Forecast By Sterility, 2020-2034
- 15.4.1. Sterile
- 15.4.2. Non-sterile
15.5. Market Value Forecast By Dosage Form, 2020-2034
- 15.5.1. Oral Medications
  - 15.5.1.1. Capsules
  - 15.5.1.2. Tablets
  - 15.5.1.3. Suspensions
  - 15.5.1.4. Others (Chewables, etc.)
- 15.5.2. Topical Medications
  - 15.5.2.1. Creams
  - 15.5.2.2. Gels
  - 15.5.2.3. Ointments
  - 15.5.2.4. Others (Paste, etc.)
- 15.5.3. Injectables
- 15.5.4. Suppositories
- 15.5.5. Others
15.6. Market Value Forecast By Application, 2020-2034
- 15.6.1. Hormone Replacement Therapy
- 15.6.2. Pain Management
- 15.6.3. Neurology
- 15.6.4. Dermatology
- 15.6.5. Ophthalmology
- 15.6.6. Sports Medicine
- 15.6.7. Nutritional Supplements
- 15.6.8. Others (ENT, Thyroid Disorders, etc.)
15.7. Market Value Forecast By Patient Demographics, 2020-2034
- 15.7.1. Human
  - 15.7.1.1. Pediatric
  - 15.7.1.2. Adult
  - 15.7.1.3. Geriatric
- 15.7.2. Veterinary
15.8. Market Value Forecast By Country/Sub-region, 2020-2034
- 15.8.1. China
- 15.8.2. India
- 15.8.3. Japan
- 15.8.4. Australia & New Zealand
- 15.8.5. Rest of Asia Pacific
15.9. Market Attractiveness Analysis
- 15.9.1. By Pharmacy Type
- 15.9.2. By Compounding Type
- 15.9.3. By Sterility
- 15.9.4. By Dosage Form
- 15.9.5. By Application
- 15.9.6. By Patient Demographics
- 15.9.7. By Country/Sub-region

16. Latin America Compounding Pharmacy Market Analysis and Forecast

16.1. Introduction
- 16.1.1. Key Findings
16.2. Market Value Forecast By Pharmacy Type, 2020-2034
- 16.2.1. 503A Pharmacies
- 16.2.2. 503B Pharmacies
16.3. Market Value Forecast By Compounding Type, 2020-2034
- 16.3.1. Pharmaceutical Ingredient Alteration (PIA)
- 16.3.2. Drug Shortage Manufacturing
- 16.3.3. Pharmaceutical Dosage Alteration (PDA)
16.4. Market Value Forecast By Sterility, 2020-2034
- 16.4.1. Sterile
- 16.4.2. Non-sterile
16.5. Market Value Forecast By Dosage Form, 2020-2034
- 16.5.1. Oral Medications
  - 16.5.1.1. Capsules
  - 16.5.1.2. Tablets
  - 16.5.1.3. Suspensions
  - 16.5.1.4. Others (Chewables, etc.)
- 16.5.2. Topical Medications
  - 16.5.2.1. Creams
  - 16.5.2.2. Gels
  - 16.5.2.3. Ointments
  - 16.5.2.4. Others (Paste, etc.)
- 16.5.3. Injectables
- 16.5.4. Suppositories
- 16.5.5. Others
16.6. Market Value Forecast By Application, 2020-2034
- 16.6.1. Hormone Replacement Therapy
- 16.6.2. Pain Management
- 16.6.3. Neurology
- 16.6.4. Dermatology
- 16.6.5. Ophthalmology
- 16.6.6. Nutritional Supplements
- 16.6.7. Others (ENT, Thyroid Disorders, etc.)
16.7. Market Value Forecast By Patient Demographics, 2020-2034
- 16.7.1. Human
  - 16.7.1.1. Pediatric
  - 16.7.1.2. Adult
  - 16.7.1.3. Geriatric
- 16.7.2. Veterinary
16.8. Market Value Forecast By Country/Sub-region, 2020-2034
- 16.8.1. Brazil
- 16.8.2. Mexico
- 16.8.3. Rest of Latin America
16.9. Market Attractiveness Analysis
- 16.9.1. By Pharmacy Type
- 16.9.2. By Compounding Type
- 16.9.3. By Sterility
- 16.9.4. By Dosage Form
- 16.9.5. By Application
- 16.9.6. By Patient Demographics
- 16.9.7. By Country/Sub-region

17. Middle East & Africa Compounding Pharmacy Market Analysis and Forecast

17.1. Introduction
- 17.1.1. Key Findings
17.2. Market Value Forecast By Pharmacy Type, 2020-2034
- 17.2.1. 503A Pharmacies
- 17.2.2. 503B Pharmacies
17.3. Market Value Forecast By Compounding Type, 2020-2034
- 17.3.1. Pharmaceutical Ingredient Alteration (PIA)
- 17.3.2. Drug Shortage Manufacturing
- 17.3.3. Pharmaceutical Dosage Alteration (PDA)
17.4. Market Value Forecast By Sterility, 2020-2034
- 17.4.1. Sterile
- 17.4.2. Non-sterile
17.5. Market Value Forecast By Dosage Form, 2020-2034
- 17.5.1. Oral Medications
  - 17.5.1.1. Capsules
  - 17.5.1.2. Tablets
  - 17.5.1.3. Suspensions
  - 17.5.1.4. Others (Chewables, etc.)
- 17.5.2. Topical Medications
  - 17.5.2.1. Creams
  - 17.5.2.2. Gels
  - 17.5.2.3. Ointments
  - 17.5.2.4. Others (Paste, etc.)
- 17.5.3. Injectables
- 17.5.4. Suppositories
- 17.5.5. Others
17.6. Market Value Forecast By Application, 2020-2034
- 17.6.1. Hormone Replacement Therapy
- 17.6.2. Pain Management
- 17.6.3. Neurology
- 17.6.4. Dermatology
- 17.6.5. Ophthalmology
- 17.6.6. Nutritional Supplements
- 17.6.7. Others (ENT, Thyroid Disorders, etc.)
17.7. Market Value Forecast By Patient Demographics, 2020-2034
- 17.7.1. Human
  - 17.7.1.1. Pediatric
  - 17.7.1.2. Adult
  - 17.7.1.3. Geriatric
- 17.7.2. Veterinary
17.8. Market Value Forecast By Country/Sub-region, 2020-2034
- 17.8.1. GCC Countries
- 17.8.2. South Africa
- 17.8.3. Rest of Middle East & Africa
17.9. Market Attractiveness Analysis
- 17.9.1. By Pharmacy Type
- 17.9.2. By Compounding Type
- 17.9.3. By Sterility
- 17.9.4. By Dosage Form
- 17.9.5. By Application
- 17.9.6. By Patient Demographics
- 17.9.7. By Country/Sub-region

18. Competition Landscape

18.1. Market Player - Competition Matrix (By Tier and Size of companies)
18.2. Market Share Analysis By Company (2023)
18.3. Company Profiles
- 18.3.1. B. Braun SE
  - 18.3.1.1. Company Overview
  - 18.3.1.2. Financial Overview
  - 18.3.1.3. Financial Overview
  - 18.3.1.4. Business Strategies
  - 18.3.1.5. Recent Developments
- 18.3.2. WEDGEWOOD PHARMACY
  - 18.3.2.1. Company Overview
  - 18.3.2.2. Financial Overview
  - 18.3.2.3. Financial Overview
  - 18.3.2.4. Business Strategies
  - 18.3.2.5. Recent Developments
- 18.3.3. Fagron
  - 18.3.3.1. Company Overview
  - 18.3.3.2. Financial Overview
  - 18.3.3.3. Financial Overview
  - 18.3.3.4. Business Strategies
  - 18.3.3.5. Recent Developments
- 18.3.4. Fresenius Kabi AG
  - 18.3.4.1. Company Overview
  - 18.3.4.2. Financial Overview
  - 18.3.4.3. Financial Overview
  - 18.3.4.4. Business Strategies
  - 18.3.4.5. Recent Developments
- 18.3.5. Avella Specialty Pharmacy
  - 18.3.5.1. Company Overview
  - 18.3.5.2. Financial Overview
  - 18.3.5.3. Financial Overview
  - 18.3.5.4. Business Strategies
  - 18.3.5.5. Recent Developments
- 18.3.6. Aurora Health Care
  - 18.3.6.1. Company Overview
  - 18.3.6.2. Financial Overview
  - 18.3.6.3. Financial Overview
  - 18.3.6.4. Business Strategies
  - 18.3.6.5. Recent Developments
- 18.3.7. Walgreen Co.
  - 18.3.7.1. Company Overview
  - 18.3.7.2. Financial Overview
  - 18.3.7.3. Financial Overview
  - 18.3.7.4. Business Strategies
  - 18.3.7.5. Recent Developments
- 18.3.8. Formul8
  - 18.3.8.1. Company Overview
  - 18.3.8.2. Financial Overview
  - 18.3.8.3. Financial Overview
  - 18.3.8.4. Business Strategies
  - 18.3.8.5. Recent Developments
- 18.3.9. Triangle Compounding
  - 18.3.9.1. Company Overview
  - 18.3.9.2. Financial Overview
  - 18.3.9.3. Financial Overview
  - 18.3.9.4. Business Strategies
  - 18.3.9.5. Recent Developments
- 18.3.10. Apollo Clinical Pharmacy
  - 18.3.10.1. Company Overview
  - 18.3.10.2. Financial Overview
  - 18.3.10.3. Financial Overview
  - 18.3.10.4. Business Strategies
  - 18.3.10.5. Recent Developments
- 18.3.11. The London Specialist Pharmacy Ltd
  - 18.3.11.1. Company Overview
  - 18.3.11.2. Financial Overview
  - 18.3.11.3. Financial Overview
  - 18.3.11.4. Business Strategies
  - 18.3.11.5. Recent Developments
- 18.3.12. Olympia Pharmacy
  - 18.3.12.1. Company Overview
  - 18.3.12.2. Financial Overview
  - 18.3.12.3. Financial Overview
  - 18.3.12.4. Business Strategies
  - 18.3.12.5. Recent Developments
- 18.3.13. Fusion Apothecary
  - 18.3.13.1. Company Overview
  - 18.3.13.2. Financial Overview
  - 18.3.13.3. Financial Overview
  - 18.3.13.4. Business Strategies
  - 18.3.13.5. Recent Developments
- 18.3.14. Albertsons Companies, Inc.
  - 18.3.14.1. Company Overview
  - 18.3.14.2. Financial Overview
  - 18.3.14.3. Financial Overview
  - 18.3.14.4. Business Strategies
  - 18.3.14.5. Recent Developments
- 18.3.15. JL Diekman and AQ Touchard
  - 18.3.15.1. Company Overview
  - 18.3.15.2. Financial Overview
  - 18.3.15.3. Financial Overview
  - 18.3.15.4. Business Strategies
  - 18.3.15.5. Recent Developments
- 18.3.16. Roseway Labs
  - 18.3.16.1. Company Overview
  - 18.3.16.2. Financial Overview
  - 18.3.16.3. Financial Overview
  - 18.3.16.4. Business Strategies
  - 18.3.16.5. Recent Developments
- 18.3.17. Hill's Compounding Pharmacy and Milford Pharmacy
  - 18.3.17.1. Company Overview
  - 18.3.17.2. Financial Overview
  - 18.3.17.3. Financial Overview
  - 18.3.17.4. Business Strategies
  - 18.3.17.5. Recent Developments
- 18.3.18. Other Prominent Players
  - 18.3.18.1. Company Overview
  - 18.3.18.2. Financial Overview
  - 18.3.18.3. Financial Overview
  - 18.3.18.4. Business Strategies
  - 18.3.18.5. Recent Developments